VOA常速英语2016--刚果开展黄热病疫苗接种工作（在线收听）

刚果开展黄热病疫苗接种工作

A preventive vaccination campaign against yellow fever was launched on August 17th in the Democratic Republic of Congo by the government. The United States, through USAID and Centers for Disease Control and Prevention, or CDC, has provided crucial support to the response to the epidemic of yellow fever.

8月17日，刚果政府展开了针对黄热病的疫苗接种工作。而美国方面也通过美国国际开发署（USAID）以及美国疾病控制与预防中心（CDC）向刚果政府对黄热病所作出的反应提供重要支持。

USAID used its approximately $1 million established PREDICT project to resupply l'Institut National de Recherche Biomédicale with needed materials to continue yellow fever diagnostics. USAID also worked through an existing partner to assist CDC to procure needed materials and person-time for a study investigating immunogenicity of the fractional/minimal dosing of yellow fever vaccine.

美国国际开发署利用其注资近100万美元的PREDICT病毒检测全球合作项目，来向刚果国家生物医学研究所（INRB）再次补给黄热病诊断的所需物资。此外，美国国际开发署还与现有合作伙伴一道协助美国疾病控制与预防中心（CDC）为某项针对黄热病少剂量加药的免疫原性研究购置其所需物资和人次。

It is estimated that the use of the fractional/minimal dosing in this campaign can confer up to a year of immunity for vaccinated individuals.

据估计，少剂量加药能为注射疫苗的人提供长达一年的黄热病免疫能力。

The study will help establish if protection actually lasts longer than one year, thereby easing pressure on a limited global stockpile of yellow fever vaccine. In terms of technical support, several experts from the CDC and USAID are working with the Congolese Ministry of health, INRB for data management, quality assurance and daily updates.

该项研究可帮助确认疫苗的防护是否能超过一年，因此能够减少由疫苗库存有限带来的压力。而来自美国疾病控制与预防中心（CDC）以及美国国际开发署（USAID）的相关专家们正与刚果卫生部以及刚果国家生物医学研究所（INRB）一道，为数据管理、质量保证以及日常更新提供技术支持。

The U.S government, through its experts, regularly participates in meetings and contributes to the identification of training needs and development programs. Many of the platforms developed to implement a successful mass polio vaccination campaign have been utilized to support the current yellow fever campaign.

美国政府派出的专家定期参加不同的会议，协助确认培训需求和发展项目。其中的很多用于大规模脊髓灰质炎疫苗接种的平台已被用于支持刚果目前的黄热病抗击中。

USAID has been funding Emerging Pandemic Threat (EPT) activities in the DRC since 2010, including training health workers to prevent, detect, and respond to epidemic threats and building lab capacity, and has an EPT budget of $17 million for Fiscal Year 2015-2017.

自2010年以来，美国国际开发署（USAID）就一直为抗击新兴流行病威胁（EPT）的数据记录控制（Data Record Control）提供资金支持，其中包括培训医疗工作人员，以阻止、探测、应对多种流行病威胁，以及构建实验能力。此外，美国国际开发署（USAID）设立了2015-2017财政年度的1700万抗击新兴流行病威胁（EPT）的预算。

The U.S government, which is also the third largest donor to GAVI -the Alliance vaccine-, supports the introduction of new vaccines through the routine system, while also providing support to the global stockpile of a few essential vaccines, including yellow fever, which can be deployed for targeted campaigns. Gavi provides over $10 million for yellow fever vaccine and operational costs to support the current vaccination campaign.

美国政府是全球疫苗免疫联盟的第三大捐献国，同时也通过该联盟体系为新疫苗的引入提供支持。此外，美国还向全球疫苗库存提供一些重要疫苗，其中包括黄热病，以用于特定疾病抗击活动的部署。全球疫苗免疫联盟捐献了1千万美元用于黄热病疫苗的研制以及运营费用，以支持刚果目前的疫苗行动。

The U.S. is proud to work with its partner the Democratic Republic of Congo to help protect the Congolese people from a deadly threat – yellow fever.

美国很自豪能够与其伙伴刚果民主共和国一道，协助保护刚果人民免受致命疾病——黄热病之灾。